Literature DB >> 30976614

Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter.

Marco Silva1, Pedro Costa Moreira1, Armando Peixoto1, Ana Luísa Santos1, Susana Lopes1, Regina Gonçalves1, Pedro Pereira1, Hélder Cardoso1, Guilherme Macedo1.   

Abstract

BACKGROUND AND AIMS: Despite the increasing use of noninvasive methods for the assessment of liver fibrosis and steatosis, the effect of fasting and food intake on these parameters is not yet clear. Our aims were to evaluate the effect of food intake on liver stiffness (LS) (measured by transient elastography) and controlled attenuation parameter (CAP) in patients with different degrees of liver disease and healthy volunteers, and secondarily, to assess possible factors associated with variations of LS and CAP.
METHODS: We performed a prospective single-center study including patients with liver disease and healthy volunteers. LS and CAP were evaluated using FibroScan® (Echosens, Paris, France), before (fasting ≥8 h) and 30 min after intake of a standardized breakfast. We used common cutoffs for LS: > 7 kPa for significant fibrosis (F2 to F4) and > 11 to 14 kPa (mean 12.5 kPa) for cirrhosis.
RESULTS: Fifty-nine (72%) patients with liver disease and 22 (28%) healthy volunteers were included. LS significantly increased 30 min after food intake (pre-meal 6.1 kPa [IQR: 4.7-9.8] vs. after-meal 6.8 kPa [IQR: 5.5-10.6]; p < 0.001). This difference was only significant in patients with chronic liver disease (p = 0.02) and not in healthy volunteers (p = 0.106). CAP values did not increase significantly after food intake. Gender, body mass index, mass of body fat, lean body mass, and percent of body fat were not related with significant variations of LS and CAP values after meal intake.
CONCLUSIONS: Significant variations of LS were observed after ingestion of a standard meal, which may have consequences for patient management. CAP values were not significantly affected by food intake. Therefore, we consider that before the isolated evaluation of CAP, it is not necessary to perform any fasting period.

Entities:  

Keywords:  Fibroscan; Healthy volunteers; Liver disease

Year:  2018        PMID: 30976614      PMCID: PMC6454378          DOI: 10.1159/000488505

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN: 2387-1954


  29 in total

Review 1.  Steatosis: co-factor in other liver diseases.

Authors:  Elizabeth E Powell; Julie R Jonsson; Andrew D Clouston
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

2.  Reproducibility and limitations of transient elastography.

Authors:  Mireen Friedrich-Rust; Stefan Zeuzem
Journal:  Liver Int       Date:  2009-05       Impact factor: 5.828

3.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

Review 4.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

5.  Role of gender upon basal and postprandial systemic and splanchnic haemodynamics in humans.

Authors:  C Szinnai; C Mottet; J P Gutzwiller; J Drewe; C Beglinger; C C Sieber
Journal:  Scand J Gastroenterol       Date:  2001-05       Impact factor: 2.423

6.  Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.

Authors:  Monica Lupşor; Radu Badea; Horia Stefănescu; Mircea Grigorescu; Zeno Sparchez; Alexandru Serban; Horatiu Branda; Sorana Iancu; Anca Maniu
Journal:  J Gastrointestin Liver Dis       Date:  2008-06       Impact factor: 2.008

Review 7.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

Authors:  Nina F Schwenzer; Fabian Springer; Christina Schraml; Norbert Stefan; Jürgen Machann; Fritz Schick
Journal:  J Hepatol       Date:  2009-06-11       Impact factor: 25.083

Review 8.  Non-invasive evaluation of liver fibrosis using transient elastography.

Authors:  Laurent Castera; Xavier Forns; Alfredo Alberti
Journal:  J Hepatol       Date:  2008-02-26       Impact factor: 25.083

9.  Comparison of the liver stiffness measurement by transient elastography with the liver biopsy.

Authors:  Ioan Sporea; Roxana Sirli; Alexandra Deleanu; Adriana Tudora; Manuela Curescu; Marioara Cornianu; Daniela Lazar
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

10.  Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome.

Authors:  Dominique Roulot; Sébastien Czernichow; Hervé Le Clésiau; Jean-Luc Costes; Anne-Claire Vergnaud; Michel Beaugrand
Journal:  J Hepatol       Date:  2008-01-03       Impact factor: 25.083

View more
  3 in total

Review 1.  Confounding factors of non-invasive tests for nonalcoholic fatty liver disease.

Authors:  Janae Wentong Wai; Charmaine Fu; Vincent Wai-Sun Wong
Journal:  J Gastroenterol       Date:  2020-05-25       Impact factor: 7.527

Review 2.  Basic concept and clinical applications of quantitative ultrasound (QUS) technologies.

Authors:  Tadashi Yamaguchi
Journal:  J Med Ultrason (2001)       Date:  2021-10-20       Impact factor: 1.314

3.  Fibroscan® probe selection for lean adults.

Authors:  Vanessa Stadlbauer; Iohanes Negrean; Andreas Posch; Andrea Streit; Nicole Feldbacher; Rudolf E Stauber; Angela Horvath
Journal:  JGH Open       Date:  2021-05-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.